CV Information
ROHIMAH MOHAMUD DR. ROHIMAH MOHAMUD
Start Year, Student Name, Category, Mode, Thesis Title, Supervisor Type
1 2024, NURUL IZZATY NAJWA BINTI ZAHARI, PHD, RESEARCH - FULL TIME, Elucidation of Stingless Bee Honey (Trigona spp.) Role as Potential Immunomodulatory Agent in Common Bacterial Community-Acquired Pneumonia Patient, CO-SUPERVISOR
2 2023, ANIS AMIERA BINTI MUHAMAD ALOJID, PHD, RESEARCH - FULL TIME, Elucidating the Mechanism of Andrographis Paniculata Targeting TNFR2 Expression Via Activation of p38 Pathway in Human Gastric Adenocarcinoma Epithelial Cells Infected by Helicobacter Pylori, CO-SUPERVISOR
3 2023, LAMBUK FATMAWATI BINTI, PHD, RESEARCH - FULL TIME, Elucidating Interaction of Tumor Necrosis Factor-alpha (TNF) and Gold Nanoparticles on Expression of Tumor Necrosis Factor Receptor 2 (TNFR2) Positive Cells in Human Peripheral Blood Lymphocytes (PBMC, CO-SUPERVISOR
4 2023, UMMUL AQEELA BALQEES BINTI MOHAMED THAHA, PHD, RESEARCH - FULL TIME, Elucidating the Cytokine Receptors and Gene Expression Profile in Patients with Systemic Lupus Erythematosus., CO-SUPERVISOR
5 2022, NURUL HAKIMAH BINTI MOHD SALIM, PHD, RESEARCH - FULL TIME, Elucidating the Role of Tumour Necrosis Factor Receptor 2 (TNFR2) and Regulatory T Cells Signalling Cascades in Modulating the Progression of sporadic young-onset colorectal cancer, CO-SUPERVISOR
6 2021, ALI SAEED ALI MUSSA, PHD, RESEARCH - FULL TIME, The Anti-Cancer and Immuno-Modulatory Effect of High-Dose Vitamin C and Low-Dose Chemotherapy on 3D Breast Cancer Cells, CO-SUPERVISOR
7 2020, MANALI HANITI BINTI MOHD ZAHID, PHD, RESEARCH - FULL TIME, Elucidating of the Mechanism of 5-Fluorouracil Loaded Gold Nanoparticles Conjugated with CD133 Antibody Targeting Survivin-Positive Colorectal Cancer Stem Cells, CO-SUPERVISOR
8 2019, WAN NURHIDAYAH BINTI WAN HANAFFI, PHD, RESEARCH - FULL TIME, INVESTIGATION OF AUNPs AS A POTENTIAL FOR TNF�ANTAGONIST MEDIATOR TARGETING TNF�TNFR2 AXIS ON COLON CANCER, MAIN SUPERVISOR
9 2018, ANIS FADHILAH BINTI ZULKIPLI, PHD, RESEARCH - PART TIME, Immunogenecity and Efficacy of Two Tuberculosis Vaccine Candidates Derived from Autochtonous Fast Growing Mycobacterium, CO-SUPERVISOR